Pegaptanib for neovascular age-related macular degeneration.
暂无分享,去创建一个
E. Gragoudas | D. Guyer | E. Cunningham | A. Adamis | Evangelos S Gragoudas | Emmett T Cunningham | Anthony P Adamis | David R Guyer | M. Feinsod | Matthew Feinsod
[1] Isaac Hartshorne,et al. New York Eye and Ear Infirmary , 1938 .
[2] J Folkman,et al. Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.
[3] Joan W. Miller,et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. , 2002, Archives of ophthalmology.
[4] K. Yamashiro,et al. VEGF164 is proinflammatory in the diabetic retina. , 2003, Investigative ophthalmology & visual science.
[5] R. D'Amato,et al. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. , 2001, The American journal of pathology.
[6] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[7] N. Bressler. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. , 2001 .
[8] A. Adamis,et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. , 1998, Investigative ophthalmology & visual science.
[9] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[10] J D Gass,et al. Pathogenesis of disciform detachment of the neuroepithelium. , 1967, American journal of ophthalmology.
[11] Greene Wr. Histopathology of age-related macular degeneration. , 1999, Molecular vision.
[12] F. Ferris,et al. Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.
[13] E S Gragoudas,et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.
[14] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[15] L. Aiello,et al. RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW , 2004, Retina.
[16] Sheela M. Waugh,et al. 2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.
[17] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[18] W R Green,et al. Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.
[19] W. B. Jeffries,et al. University of Vermont College of Medicine. , 2010, Academic medicine : journal of the Association of American Medical Colleges.
[20] J. Folkman,et al. Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .
[21] Joan W. Miller,et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. , 1996, Archives of ophthalmology.
[22] L. Aiello,et al. EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS , 2004, Retina.
[23] A Mathis,et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. , 1994, Archives of ophthalmology.
[24] C. Walker. Ophthalmology , 1859, Bristol medico-chirurgical journal.
[25] J. L.. VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC RETINOPATHY AND OTHER RETINAL DISORDERS , 1995, Pediatrics.
[26] E. Bass,et al. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. , 2004, American journal of ophthalmology.
[27] G. Lutty,et al. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. , 2002, American journal of ophthalmology.
[28] R. Klein,et al. Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.
[29] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[30] W. Green,et al. Histopathology of age-related macular degeneration. , 1999, Molecular vision.
[31] P. Kertes,et al. POTENTIAL PUBLIC HEALTH IMPACT OF AGE-RELATED EYE DISEASE STUDY RESULTS: AREDS REPORT NO. 11 , 2004 .